CCSA approves plan to buy 50,000 courses of anti-viral Molnupiravir drug
Thailand’s Centre for COVID-19 Situation Administration (CCSA) today (Thursday) approved the Public Health Ministry’s proposal to procure 50,000 courses of the anti-viral Molnupiravir drug, made by US pharmaceutical company Merck.…
